IR
CNMD icon

Invictus RG’s CONMED CNMD Stock Holding History

Invictus RG’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,685
Closed -$371K – 37
2018
Q3 		$371K Buy
+4,685
New +$362K 0.28% 97
2018
Q2 		– Sell
-6,165
Closed -$390K – 220
2018
Q1 		$390K Buy
+6,165
New +$368K 0.26% 82
2017
Q3 		– Sell
-121
Closed -$6K – 526
2017
Q2 		$6K Buy
+121
New +$5.99K ﹤0.01% 577

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invictus RG's CNMD Position: Q4 2018 in Review

Invictus RG sold out of CONMED (CNMD) in Q4 2018, closing a stake of 4,685 shares — an estimated $371K sold.

Invictus RG first reported a position in CNMD in Q2 2017 and held it in 3 quarters. The position peaked at $390K in Q1 2018. 207 funds tracked by Wall St. Rank hold CNMD as of Q4 2018.

  • Invictus RG reported no remaining CONMED position as of Q4 2018 after selling out during the quarter.
  • Invictus RG sold 4,685 CONMED shares in Q4 2018, an estimated $371K.
  • Invictus RG first reported a position in CONMED in Q2 2017 and held it in 3 quarters.
  • Invictus RG's CONMED position peaked at $390K in Q1 2018.
  • 207 funds tracked by Wall St. Rank held CONMED as of Q4 2018.

Based on Invictus RG's 13F filing for Q4 2018, filed 13 Feb 2019.